Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Cash & Equivalents (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Cash & Equivalents readings, the most recent being $90.6 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 30.91% to $90.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $90.6 million, a 30.91% increase, with the full-year FY2025 number at $90.6 million, up 30.91% from a year prior.
  • Cash & Equivalents hit $90.6 million in Q4 2025 for Tandem Diabetes Care, down from $91.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $172.5 million in Q4 2022 to a low of $47.7 million in Q2 2024.
  • Median Cash & Equivalents over the past 5 years was $91.3 million (2025), compared with a mean of $91.5 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 142.36% in 2022 and later crashed 65.88% in 2023.
  • Tandem Diabetes Care's Cash & Equivalents stood at $71.2 million in 2021, then skyrocketed by 142.36% to $172.5 million in 2022, then crashed by 65.88% to $58.9 million in 2023, then grew by 17.61% to $69.2 million in 2024, then surged by 30.91% to $90.6 million in 2025.
  • The last three reported values for Cash & Equivalents were $90.6 million (Q4 2025), $91.9 million (Q3 2025), and $64.1 million (Q2 2025) per Business Quant data.